Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFalpha treatment

Ann Rheum Dis. 1999 Nov;58 Suppl 1(Suppl 1):I61-4. doi: 10.1136/ard.58.2008.i61.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / therapy*
  • Clinical Trials as Topic
  • Humans
  • Infliximab
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / immunology*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab